Remdesivir oral (Vivtex Corp)

N/A

Report date: 2024/06/04 16:17:35

Base Information

Drug NameRemdesivir oral (Vivtex Corp)
Drug Alias NameN/A
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Nucleoside analogues
Mechanisms of ActionRNA-directed RNA polymerase inhibitorsViral proteins inhibitors
TargetsRNA-directed RNA polymeraseViral proteins
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesVivtex Corp
China Registration ClassN/A

Develop Information

Active CompaniesVivtex Corp
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A